We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Cipla and Jiangsu Acebright Pharmaceutical announced that they have entered into an agreement to set up a joint venture company in the People’s Republic of China.
Cipla (EU) Limited, a U.K.-based wholly-owned subsidiary of the leading global pharmaceutical company Cipla Limited and Jiangsu Acebright Pharmaceutical Co. Ltd. have announced that they have entered into an agreement to set up a joint venture company ("